Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable?

被引：1
作者：
Marin, Francisco [3 ]
Roldan, Vanessa [2 ]
Lip, Gregory Y. H. [1 ]
机构：
[1] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England
[2] Univ Murcia, Cardiol Unit, Hosp Univ Virgen Arrixaca, Murcia, Spain
[3] Univ Murcia, Hosp Univ Morales Meseguer, Hematol & Med Oncol Unit, Murcia, Spain
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2012年 / 13卷 / 08期
关键词：
atrial fibrillation; dabigatran; RE-LY trial; warfarin; COST-EFFECTIVENESS; EUROPEAN-SOCIETY; WARFARIN; EVENTS; ASSOCIATION; GUIDELINES; MANAGEMENT; ETEXILATE; DOCUMENT; RISK;
D O I：
10.1517/14656566.2012.688954
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：1087 / 1090
页数：4
相关论文
共 28 条
[1]   New oral anticoagulant drugs in cardiovascular disease [J].
Ahrens, Ingo ;
Lip, Gregory Y. H. ;
Peter, Karlheinz .
THROMBOSIS AND HAEMOSTASIS, 2010, 104 (01) :49-60
[2]  
Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690
[3]  
Albers GW, 2003, LANCET, V362, P1691
[4]   Guidelines for the management of atrial fibrillation (vol 31, pg 2369, 2010) [J].
Camm, A. J. .
EUROPEAN HEART JOURNAL, 2011, 32 (09) :1172-1172
[5]  
Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]
[6]   Newly Identified Events in the RE-LY Trial [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Reilly, Paul A. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19) :1875-1876
[7]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[8]  
DiNicolantonio JJ, 2012, EXPERT OPIN PHARMACO
[9]   WARFARIN IN THE PREVENTION OF STROKE ASSOCIATED WITH NONRHEUMATIC ATRIAL-FIBRILLATION [J].
EZEKOWITZ, MD ;
BRIDGERS, SL ;
JAMES, KE ;
CARLINER, NH ;
COLLING, CL ;
GORNICK, CC ;
KRAUSESTEINRAUF, H ;
KURTZKE, JF ;
NAZARIAN, SM ;
RADFORD, MJ ;
RICKLES, FR ;
SHABETAI, R ;
DEYKIN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (20) :1406-1412
[10]  
EZEKOWITZ MD, 1993, NEW ENGL J MED, V328, P148
123